当前位置:首页 >英文主页 >中英对照 > 报告详情

艾昆纬:2026推进中东与非洲地区个性化肿瘤疗法公平及时可及白皮书(英文版)(12页).pdf

上传人: 1****1 编号:1162903 2026-03-23 12页 2.54MB

下载:

1、MARCH2026Summary Highlights from a Multi-Stakeholder Panel Discussion at the 13th Annual Emirates Oncology Conference in November 2025Advancing Equitable and Timely Access to Personalized Oncology Therapies:Middle East and Africa SUMMARYTable of Contents2026 IQVIA and its affiliates.All reproduction

2、 rights,quotations,broadcasting,publications reserved.No part of this publication may be reproduced or transmitted in any form or by any means,electronic or mechanical,including photocopy,recording,or any information storage and retrieval system,without express written consent of IQVIA and the IQVIA

3、 Institute.REFERENCING THIS REPORTPlease use this format when referencing content from this report:Source:IQVIA Institute for Human Data Science.Advancing Equitable and Timely Access to Personalized Oncology Therapies:Middle East and Africa.March 2026.Advancing Equitable and Timely Access to Persona

4、lized Oncology Therapies:Middle East and Africa.Panelists 1 Introduction 2Background 2Highlights from the panel discussion 3 Barriers to oncology therapy access across regions 3 Ongoing initiatives and solutions to improve access 4A call-to-action 6References 7About the Institute 8iqviainstitute.org

5、|1PanelistsEXTERNAL SPEAKERSH.E.DR.MOUZA BIN HAMROUR AL AMERIBreast Surgeon,Chief of Breast Care Center,Tawam Hospital/SEHADR.KHALED ABDEL-AZIZ KAMAL Consultant of Clinical Oncology at Ain Shams University,Executive Director of the Presidential Initiative for Cancer Early Detection and Management DR

6、.MOHAMMAD AL NAHEDH Director,Pharmaceutical Care Division,Clinical Pharmacy Consultant,Hematology/Oncology,King Faisal Specialist Hospital and Research Center DR.JACQUES SNYMAN Director and owner of Forte Research Co.(Pty)Ltd,Consultant for Pharmacology Research and HTAMODERATORMURRAY AITKENExecutiv

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
1. **背景与目标**:2025年11月阿布扎比多利益相关者圆桌讨论,聚焦中东和非洲精准肿瘤疗法的公平及时获取,基于IQVIA 2025年8月报告,旨在缩小区域差距。 2. **核心障碍**: - **监管与报销碎片化**:如阿联酋多部门审批延迟、沙特SFDA谈判冗长、埃及多保险体系差异导致覆盖不均。 - **财务与系统限制**:南非85%人口依赖公共报销(仅覆盖WHO基本药物),15%私人保险可获创新疗法;埃及货币贬值加剧成本敏感性。 - **诊断能力不足**:伴随诊断集中于中心城市,基层医疗资源匮乏。 3. **解决方案**: - **加速审批**:沙特SFDA快速通道、阿联酋新成立Emirati Drug Establishment推动统一框架。 - **区域协作**:埃及集中基因检测降低成本,南非探索风险均等基金及创新报销模式。 - **数据与制造**:标准化真实世界数据(RWE)收集,加强本地化生产以减少供应链风险。 4. **行动呼吁**:7大方向包括统一采购、患者参与决策、HTA框架整合等,以实现公平可及。
癌症治疗困境? 精准医疗如何普及? 中东非洲抗癌差距?
客服
商务合作
小程序
服务号
折叠